US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

248.72

-0.9300-0.37%

Post-market: 250.001.28+0.51%19:59 EDT

Volume:344.92K

Turnover:86.47M

Market Cap:565.71M

PE:- -

High:259.39

Open:256.76

Low:244.53

Close:249.65

52wk High:341.93

52wk Low:95.98

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.06

T/O Rate:15.16%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Oncolytics Advances Pelareorep Trial, Gains FDA Alignment

Powerful NeOnc Brain Cancer Pipeline Advances

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and Agilon Health (AGL)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ascendis Pharma (ASND), Lakefront Biotherapeutics (LKFT) and 10x Genomics (TXG)

Health Care Select Sector SPDR: Pivot points

Bayer announces FDA accepts Lynkuet sNDA for Priority Review

NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212

Palvella receives third year of grant funding from FDA for QTORIN

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and IQVIA Holdings (IQV)

U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)

National Healthcare Properties says has LOIs for $244M of SHOP acquisitions

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

India’s Top Court Clears Independent Forensic Audit of IHH’s Fortis Unit, Limits Impact of Delhi Ruling

Court Dismisses Molina Healthcare Securities Fraud Complaint, Allows Plaintiff to Amend

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection

Jianyou Pharmaceutical's Subsidiary Gains US FDA Approval for Vitamin B1 Injection Product

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/LABU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":248.72,"timestamp":1790971200000,"preClose":249.65,"halted":0,"volume":344920,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"delay":0,"changeRate":-0.003725215301422018,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Closed","change":-0.93,"latestTime":"10-02 16:00:00 EDT","open":256.755,"high":259.39,"low":244.53,"amount":86471147.3688,"amplitude":0.059523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":248.875,"aum":566062383.8,"dividendRate":0.003633,"bidAskSpread":0.003777,"preHourTrading":{"tag":"盘前","latestPrice":256,"preClose":249.65,"latestTime":"09:27 EDT","volume":5553,"amount":1438964.4383999999,"timestamp":1790947678782,"change":6.35,"changeRate":0.025436,"amplitude":0.043381},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"volumeRatio":1.05546,"impliedVol":0.9378,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.05546,"shares":2274486,"dividePrice":0.9037,"high":259.39,"amplitude":0.059523,"preClose":249.65,"low":244.53,"week52Low":95.98,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":248.72,"eps":0,"divideRate":0.003633,"volume":344920,"delay":0,"ttmEps":0,"open":256.755,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":252.47,"twentyDayClose":305.86,"sixtyDayClose":324.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670258046","title":"Oncolytics Advances Pelareorep Trial, Gains FDA Alignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2670258046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670258046?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:58","pubTimestamp":1790603935,"startTime":"0","endTime":"0","summary":"An announcement from Oncolytics Biotech ( ($ONCY) ) is now available. On September 28, 2026, Oncolytics Biotech reported operational progress in it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncolytics-advances-pelareorep-trial-gains-fda-alignment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncolytics-advances-pelareorep-trial-gains-fda-alignment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670309255","title":"Powerful NeOnc Brain Cancer Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2670309255","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670309255?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:51","pubTimestamp":1790603460,"startTime":"0","endTime":"0","summary":"November 17 FDA Meeting Set to Discuss Dosing and Trial Size for Second Drug in PipelineDENVER, Sept.  28, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369955/0/en/powerful-neonc-brain-cancer-pipeline-advances.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NTHI","LABU","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670523034","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2670523034","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670523034?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:00","pubTimestamp":1790600407,"startTime":"0","endTime":"0","summary":"Healthcare stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down a slight 0.2%.Kodiak Sciences  stock was up more than 99% after the company said its two experimental eye drugs, Zenkuda and tabirafusp-ted, met primary endpoints in a Phase 3 study in patients with wet age-related macular degeneration.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","LU0029874061.USD","KOD","IBB","LU0128526141.USD","BK4581","BK4139","BK4505","BK4588","HCSG","LABU","XLV","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670342230","title":"Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and Agilon Health (AGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670342230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670342230?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:51","pubTimestamp":1790599908,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hinge Health, Inc. Class A (HNGE) and Agilon Healt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hinge-health-inc-class-a-hnge-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hinge-health-inc-class-a-hnge-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","XLV","LABU","HCSG","XBI","BK4585","LU0128526141.USD","BK4539","HNGE","AGL","BK4137","BK4588","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237166","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ascendis Pharma (ASND), Lakefront Biotherapeutics (LKFT) and 10x Genomics (TXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237166?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:30","pubTimestamp":1790598641,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ascendis Pharma (ASND), Lakefront Biotherapeutics ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ascendis-pharma-asnd-lakefront-biotherapeutics-lkft-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ascendis-pharma-asnd-lakefront-biotherapeutics-lkft-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0963586101.USD","BK4548","FMED","BK4137","BK4585","XBI","LU0109394709.USD","ARKG","BK4139","LU0029874061.USD","LU1861558580.USD","HCSG","BK4121","BK4588","BK4581","LU0889565916.HKD","LU0128526141.USD","ASND","MEDI","LABU","LU1861559042.SGD","LU0320765992.SGD","XLV","TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237949","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237949","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237949?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:27","pubTimestamp":1790598430,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $171.99, Pivot Low: $169.68. These were calculated usi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-151?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-151?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670623274","title":"Bayer announces FDA accepts Lynkuet sNDA for Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2670623274","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670623274?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:10","pubTimestamp":1790597423,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that the U.S. Food and Drug Administration has accepted the company’s supplemental New Drug Application and granted Priorit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-announces-fda-accepts-lynkuet-snda-for-priority-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-announces-fda-accepts-lynkuet-snda-for-priority-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4007","BAYRY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232424","title":"NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232424","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232424?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:00","pubTimestamp":1790596800,"startTime":"0","endTime":"0","summary":"November 17 meeting will address Phase 2 study design and potential regulatory pathwaysCALABASAS, Calif., Sept.  28, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369839/0/en/neonc-technologies-announces-fda-end-of-phase-1-meeting-for-neo212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4585","LABU","BK4588","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234701","title":"Palvella receives third year of grant funding from FDA for QTORIN","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234701","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234701?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:50","pubTimestamp":1790596216,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics (PVLA) announced that the Company has received a third year of grant funding from the FDA Office of Orphan Products Developme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palvella-receives-third-year-of-grant-funding-from-fda-for-qtorin-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palvella-receives-third-year-of-grant-funding-from-fda-for-qtorin-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVLA","BK4585","LABU","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234690","title":"Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and IQVIA Holdings (IQV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234690?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:32","pubTimestamp":1790595120,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xencor (XNCR) and IQVIA Holdings (IQV) with bullish ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xencor-xncr-and-iqvia-holdings-iqv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xencor-xncr-and-iqvia-holdings-iqv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1201861165.SGD","LU1791710400.SGD","LU0029874061.USD","HEAL","BK4581","IQV","LU0648000940.SGD","LU1791710582.SGD","LU0882574055.USD","LU1989764748.USD","EKG","LU0130518102.USD","LU0477156797.USD","LU0130103400.USD","LU0648001328.SGD","XNCR","LU0980610538.SGD","LU1989764664.SGD","LU1201861249.SGD","BK4588","LU1261432733.SGD","LU0128526141.USD","LU0528227936.USD","LU0130517989.USD","LU0477156953.USD","BK4121","HCSG","XLV","LU0198837287.USD","XBI","BK4137","BK4530","BK4585","BK4139","LU0130102774.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234567","title":"U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234567","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234567?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595000,"startTime":"0","endTime":"0","summary":"NDA submission completed following positive Phase 3 SELVA results; potential U.S. commercial launch in the first half of 2027, if approved QTORIN rapamycin has the potential to become the first FDA-ap","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369784/0/en/u-s-food-and-drug-administration-awards-additional-funding-for-qtorin-rapamycin-for-the-treatment-of-microcystic-lymphatic-malformations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYLG","BMED","IDNA","MEDX","BK4585","LABU","GDOC","NVIB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239323","title":"Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239323?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:30","pubTimestamp":1790591429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on RegenXBio (RGNX), Benitec Biopharma (BNTC) and Vaxcy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-benitec-biopharma-bntc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-benitec-biopharma-bntc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","BK4139","BK4585","BK4137","XBI","XLV","LABU","BNTC","BK4563","RGNX","LU0128526141.USD","BK4505","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239368","title":"National Healthcare Properties says has LOIs for $244M of SHOP acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239368?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:25","pubTimestamp":1790591155,"startTime":"0","endTime":"0","summary":"The company currently has signed purchase and sale agreements or non-binding letters of intent for approximately $244M of SHOP acquisitions, compri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/national-healthcare-properties-says-has-lois-for-244m-of-shop-acquisitions-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/national-healthcare-properties-says-has-lois-for-244m-of-shop-acquisitions-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1712237335.SGD","BK4613","LU2357305700.SGD","LU1720051017.SGD","LU2063271972.USD","LU1720051108.HKD","LU1429558221.USD","LU2265009873.SGD","SHPU","BK4566","LU1804176565.USD","LU1861558580.USD","BK4524","LABU","LU2326559502.SGD","NHP","BK4116","BK4581","LU0823421416.USD","BK4225","BK4551","BK4585","BK4528","SHOP","LU1691799644.USD","XBI","LU1435385759.SGD","BK4588","SHPD","LU0823421333.USD","XLV","BK4548","LU1548497426.USD","LU1623119135.USD","LU0390134368.USD","LU1861559042.SGD","LU0081259029.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670398762","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670398762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670398762?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:20","pubTimestamp":1790590815,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Bioscience...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neogen-neog-larimar-therapeutics-lrmr-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neogen-neog-larimar-therapeutics-lrmr-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT","BK4198","BK4137","LABU","BK4585","LU0029874061.USD","LU2211817866.USD","NEOG","BK4581","BK4139","LU0128526141.USD","XBI","LRMR","HCSG","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236928","title":"Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590220,"startTime":"0","endTime":"0","summary":"With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. FDA approval of Ziihera for first-line HER2-positive advanc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBPH","BMED","MRNX","TECB","MEDI","GDOC","GNMX","LABU","LFSC","IYH","MRNY","BK4007","BK4588","NVIB","FRTY","IDNA","XLVX","BBP","PSCH","IEIH","SYNB","RSPH","PINK","IBB","BK4585","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235109","title":"India’s Top Court Clears Independent Forensic Audit of IHH’s Fortis Unit, Limits Impact of Delhi Ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235109","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670235109?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:57","pubTimestamp":1790589456,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) has issued an update. IHH Healthcare Berhad disclosed that the Supreme Court of India has disposed of a Special Lea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indias-top-court-clears-independent-forensic-audit-of-ihhs-fortis-unit-limits-impact-of-delhi-ruling?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indias-top-court-clears-independent-forensic-audit-of-ihhs-fortis-unit-limits-impact-of-delhi-ruling?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","BK4581","MNDmain","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670246233","title":"Court Dismisses Molina Healthcare Securities Fraud Complaint, Allows Plaintiff to Amend","url":"https://stock-news.laohu8.com/highlight/detail?id=2670246233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670246233?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:26","pubTimestamp":1790587564,"startTime":"0","endTime":"0","summary":"A federal judge has dismissed the consolidated securities fraud complaint against Molina Healthcare ($MOH) and two of its executives, while allowin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/court-dismisses-molina-healthcare-securities-fraud-complaint-allows-plaintiff-to-amend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/court-dismisses-molina-healthcare-securities-fraud-complaint-allows-plaintiff-to-amend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","PSCH","SG9999014013.SGD","XBI","SG9999014005.SGD","SG9999014021.USD","XLV","SG9999014039.USD","BK4588","BK4581","BK4154","BK4532","BK4585","MOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670391233","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2670391233","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670391233?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:14","pubTimestamp":1790586840,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369620/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","LU0128526141.USD","BK4581","BK4137","LABU","BK4585","XBI","XLV","LU0029874061.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112995199","title":"Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1112995199","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112995199?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:10","pubTimestamp":1790586629,"startTime":"0","endTime":"0","summary":"Dezhan Healthcare Company Limited (000813.SZ) has announced that its wholly-owned subsidiary, Beijing Honghui Xin Pharmaceutical Technology Co., Ltd., recently received notification from the U.S....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","000813","BMED","LNGR","BK1161","PSYK","BK0114","IBBQ","BK1574","BK0060","MDTX","MEDX","BK0239","BK4588","LABU","159992","BK4585","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185130345","title":"Jianyou Pharmaceutical's Subsidiary Gains US FDA Approval for Vitamin B1 Injection Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1185130345","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185130345?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:40","pubTimestamp":1790584825,"startTime":"0","endTime":"0","summary":"Jianyou Pharmaceutical (603707.SH) has announced that its subsidiary, Hong Kong Jianyou Industrial Co., Ltd. (\"Hong Kong Jianyou\"), recently received an ANDA approval notice (ANDA number: 213131)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0186","BK0046","BK4585","LABU","603707","BK0239","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":9,"totalSize":395,"code":"91000000","status":"200"}]}}